Aligato, Jay-ar P.
HRN: 22-07-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/13/2022
12/19/2022
IVT
225mg
Q6
Urti
Waiting Final Action
Indication: Prophylaxis Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes